Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManx Financial Regulatory News (MFX)

Share Price Information for Manx Financial (MFX)

Share Price is delayed by 15 minutes
Get Live Data
23.50    -1.00 (-4.08%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £28.89m
MFX Live PriceLast checked at - London Stock Exchange

Intraday Manx Financial Share Chart

Director/PDMR Shareholding

21 Nov 2025 07:00

RNS Number : 4113I
Manx Financial Group PLC
21 November 2025
 

 

FOR IMMEDIATE RELEASE 21 November 2025

 

 

Manx Financial Group PLC (the 'Company')

Director's Dealing

 

The Company was informed on 20 November 2025 that Hargreaves Lansdown (Nominees) Limited as nominee for Mr James Smeed, a Director of the Company, purchased 25,000 Ordinary Shares in the Company at a price of 27.45 pence per share on 20 November 2025.

As a result of this purchase the total holding of Ordinary Shares held by Hargreaves Lansdown (Europe) Limited as nominee for Mr Smeed is 200,000 representing 0.17% of the issued ordinary share capital of the Company. 

 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For further information, please contact:

Manx Financial Group PLC

Beaumont Cornish Limited

Tavistock Communications Limited

Greentarget Limited

Denham Eke

Roland Cornish/

James Biddle

Simon Hudson/

Adam Baynes

Jamie Brownlee

Tel: +44 (0) 1624 694694

Tel: +44 (0) 20 7628 3396

Tel: +44 207 920 3150 mfg@tavistock.co.uk

Tel: +44 (0) 20 3307 5726

 

Nominated Adviser

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXBDBUSDDGUG
Date   Source Headline
21st Sep 20237:00 amRNSUnaudited Interim Results to 30 June 2023
17th Jul 20232:24 pmRNSUpdate regarding Issue of Ordinary Shares
12th Jul 20237:00 amRNSIssue of Shares pursuant to Scrip Dividend & TVR
19th Jun 20237:00 amRNSScrip Share Price
30th May 202312:30 pmRNSResult of AGM and Dividend Declaration
5th May 20237:00 amRNSNotice of AGM
21st Mar 20237:00 amRNSFinal Results
15th Dec 202212:37 pmRNSHolding(s) in Company
12th Dec 20226:12 pmRNSHolding(s) in Company
27th Oct 20229:00 amRNSGrant of Restricted Share Units
27th Oct 20227:00 amRNSConister applies for UK Branch banking licence
27th Sep 20227:00 amRNSInterim Results for the 6 months to 30 June 2022
21st Sep 20227:00 amRNSAcquisition of 50.1% interest in Payment Assist
22nd Jul 20227:00 amRNSExtension of Unsecured Convertible Loan Notes
7th Jul 20227:00 amRNSGrant of Restricted Share Units
23rd Jun 20229:01 amRNSPrice Monitoring Extension
17th Jun 202212:42 pmRNSNew Shares issued pursuant to Scrip Dividend, TVR
9th Jun 20227:00 amRNSScrip Share Price
26th May 20227:00 amRNSConister Bank Limited appoints new Chairman
25th May 202212:16 pmRNSResult of AGM & Dividend Declaration
16th May 20227:00 amRNSConditional Acquisition of 50.1% interest in PAL
29th Apr 20228:00 amRNS2022 Annual General Meeting
10th Mar 20227:00 amRNSReport and Accounts for the year ended 31 Dec 2021
11th Jan 20223:54 pmRNSChange to Director Holdings
11th Jan 20229:39 amRNSChange to Director Holdings
4th Nov 20217:00 amRNSChanges to Group Boards
11th Oct 20217:00 amRNSAcquisition of Additional 60% Shareholding in BLX
29th Sep 202112:00 pmRNSUnaudited Interim Results to 30 June 2021
3rd Sep 20217:00 amRNSTotal Voting Rights
24th Aug 202110:39 amRNSFurther UK Government-backed lending accreditation
13th Aug 20217:00 amRNSDirector/PDMR Shareholding
6th Aug 20217:00 amRNSIssue of Ordinary Shares and TVR
21st Jul 20217:00 amRNSScrip Share Price
7th Jul 202112:05 pmRNSResult of EGM and Dividend Declaration
15th Jun 20217:00 amRNSNotice of EGM
14th Jun 20217:00 amRNSAcquisition of Additional Shareholding in BSL
9th Jun 20217:00 amRNSAcquisition of Shareholding in Rivers Finance
4th Jun 20217:00 amRNSMFX ENTERS THE SME DEBT MANAGEMENT MARKET
3rd Jun 20217:00 amRNSResult of AGM
5th May 20217:00 amRNSNotice of AGM
4th Mar 20217:00 amRNSReport and Accounts to 31 December 2020
14th Jan 20217:00 amRNSGovernment-backed lending increase
23rd Dec 20207:00 amRNSDividend Scheme Announced
15th Oct 20207:00 amRNSManx Financial raises £2m of additional capital
28th Aug 20207:00 amRNSHalf-year Report
21st Aug 20207:00 amRNSGovernment Lending Schemes
7th Aug 20202:04 pmRNSResult of AGM
15th Jul 20207:00 amRNSNotice of AGM
30th Jun 20207:00 amRNSFinal Results
4th Jun 202010:13 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.